AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-MEDICAL LABORATORIES
Aclarion, Inc. Common Stock
XNAS · usd
SIC 8071 · SERVICES-MEDICAL LABORATORIES
FIGI BBG014FBN5N7
1.93▼ 0.01 (-0.26%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
1.94
Day's Range
1.88 – 1.97
52-Week Range
1.85 – 9.37
Volume
10.1K
Avg Volume
34.4K
Share Statistics
Shares Outstanding
Employees
11
Exchange
XNAS
Listed
2022-04-22
Share count as of August 4, 2026

Aclarion, Inc. Common Stock (ACON) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Aclarion, Inc. Common Stock (ACON)
What is Aclarion, Inc. Common Stock's Market Cap?
Aclarion, Inc. Common Stock's Market Cap is $5.6M, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's Enterprise Value?
Aclarion, Inc. Common Stock's Enterprise Value is -$10.7M, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's Price / Sales?
Aclarion, Inc. Common Stock's Price / Sales is 66.4×, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's EV / Revenue?
Aclarion, Inc. Common Stock's EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's EV / EBITDA?
Aclarion, Inc. Common Stock's EV / EBITDA is 1.1×, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's Revenue (TTM)?
Aclarion, Inc. Common Stock's Revenue (TTM) is $83.8K, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's Net Income (TTM)?
Aclarion, Inc. Common Stock's Net Income (TTM) is -$9.2M, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's EBITDA?
Aclarion, Inc. Common Stock's EBITDA is -$9.5M, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's Diluted EPS (TTM)?
Aclarion, Inc. Common Stock's Diluted EPS (TTM) is -3.19, based on as-reported figures from SEC (XBRL) filings.
What is Aclarion, Inc. Common Stock's EBITDA Margin?
Aclarion, Inc. Common Stock's EBITDA Margin is -11302.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · ACONAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Revenue:
Revenue
YoY growth+30.5%+11.3%+80.6%+31.5%
Cost of Revenue
Gross profit
% of revenue32.9%17.7%9.7%23.2%
Operating expenses:
Selling, General and Administrative Expense
Research and Development Expense
Total operating expenses
% of revenue11536.1%14147.1%10794.9%9689.3%
Loss from operations
% of revenue-11503.2%-14129.3%-10785.2%-9666.2%
Other income (expense):
Non-Operating Income (Expense)
Penalties and settlements
Interest Income——
Total other income (expense)
Loss before income taxes
Income Tax Expense
Net loss
% of revenue-10899.5%-13498.5%-10223.2%-9008.0%
Dividends on preferred stock
Net loss allocable to common stockholders
Earnings Per Share (Basic)
Earnings Per Share (Diluted)